Skip to content
NewsBlazeIN – Lifestyle
Author:
Psyence Biomedical Ltd.
Psyence BioMed Announces Exclusive U.S. Ibogaine Licence for Texas Ibogaine Research Corporation
September 28, 2026
Psyence BioMed Announces Strategic Ibogaine Investment
September 23, 2026
Psyence BioMed Establishes Texas Ibogaine Research Corporation to Advance U.S. Ibogaine Development
September 14, 2026